Pyoderma: Difference between revisions

(Text replacement - "Tx" to "treatment")
Line 53: Line 53:
*Medical management
*Medical management
**Small ulcers - steroid cream/injections, silvadene compression dressings, PO antibiotics like [[dapsone]] or [[minocycline]]
**Small ulcers - steroid cream/injections, silvadene compression dressings, PO antibiotics like [[dapsone]] or [[minocycline]]
**Severe - steroids, immunologic treatment, biologics, IVIG, plasmapheresis
**Severe - [[steroids]], immunologic treatment, biologics, [[IVIG]], plasmapheresis


==Disposition==
==Disposition==

Revision as of 01:11, 10 October 2016

Background

  • 1/100,000 people per year in US, primarily 40s-50s year of age
  • Dysfunction of activated neutrophils
  • >50% associated with systemic disease:
    • IBD
    • Polyarthritis, sero-negative and -positive
    • Leukemia
    • Less commonly psoriatic arthritis, OA, RA, spondyloarthopathy, hepatitis, PBC, myelomas, SLE, Sjogren

Clinical Features

  • Extracutaneous manifestations (due to sterile neutrophilic infiltrates)
    • Culture-negative pulmonary infiltrates most common
    • CV, CNS, GI, eyes, liver, spleen, bones, LNs
  • Features
    • Initial lesion - bite-like, small, red papule or pustule (many patients attribute spider bite)
    • Changes into larger, ulcerative lesion
    • Two primary variants:
      • Classic ulcerative form - usually on legs, deep ulceration, violaceous border along ulcer bed
      • Superficial, atypical form - hands/forearms/face, vesiculopustular
    • Less common variants: 1) Peristomal pyoderma, 2) Genital pyoderma (must differentiate from STI), 3) Pyostomatitis vegetans (intraoral)

Differential Diagnosis

  • Pyoderma is Dx of exclusion
  • Systemic diseases
    • Neutrophilic dermatoses (Sweet, Behcet, etc.)
    • Calciphylaxis - very important to differentiate due to treatment
    • Arterial/venous insufficiency
    • Blastomycosis
    • Hidradenitis suppurative
    • TB gumma, mycobacterial infections
    • Malignancy (squamous cell)
    • Vasculitis
    • Ecthyma gangrenosum (pseudomonas)

Travel-related skin conditions

See also domestic U.S. ectoparasites

Evaluation

  • No specific criteria
  • Labs
    • CBC, CMP, UA, hepatitis profile
    • Tissue cultures (comprehensive, all organisms)
    • VDRL
    • ANCA
    • Coags
    • Anti-phospholipid AB
    • Referral for heme malignancy workup
    • Referral for IBD workup
  • Imaging - CXR if systemic disease suspected

Management

  • Nonsurgical management
    • Necrotic tissue should be gently removed
    • Wide surgical debridement results in enlargement of ulcer
  • Medical management
    • Small ulcers - steroid cream/injections, silvadene compression dressings, PO antibiotics like dapsone or minocycline
    • Severe - steroids, immunologic treatment, biologics, IVIG, plasmapheresis

Disposition

  • Dermatology referral, consider surgical if suspecting other necrotizing diseases requiring debridement

See Also

External Links

References